Co-Authors
This is a "connection" page, showing publications co-authored by Tony Mazzulli and Jonathan Gubbay.
Connection Strength
1.087
-
Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results. Infect Control Hosp Epidemiol. 2021 Aug 09; 1-5.
Score: 0.240
-
Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic. PLoS One. 2021; 16(7):e0253941.
Score: 0.239
-
Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada. Virol J. 2018 06 05; 15(1):98.
Score: 0.193
-
Whole-genome Sequencing for Surveillance of Invasive Pneumococcal Diseases in Ontario, Canada: Rapid Prediction of Genotype, Antibiotic Resistance and Characterization of Emerging Serotype 22F. Front Microbiol. 2016; 7:2099.
Score: 0.174
-
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories. J Clin Virol. 2020 07; 128:104433.
Score: 0.055
-
Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015. Euro Surveill. 2019 Mar; 24(11).
Score: 0.051
-
The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014. PLoS One. 2017; 12(8):e0181172.
Score: 0.046
-
Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015. Emerg Infect Dis. 2017 07; 23(7):1063-1069.
Score: 0.045
-
Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada. Antiviral Res. 2017 04; 140:158-163.
Score: 0.044